The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
CARA THERAPEUTICS INCCOM14075510970,2633,268,057SH SOLE 3,268,05700
LIVEXLIVE MEDIA INCCOM NEW53839L20815,2043,663,540SH SOLE 3,663,54000
MERSANA THERAPEUTICS INCCOM59045L1063,226796,458SH SOLE 796,45800
NGM BIOPHARMACEUTICALS INCCOM62921N10555,1443,766,667SH SOLE 3,766,66700
SENSEONICS HLDGS INCCOM81727U105326159,601SH SOLE 159,60100